Published in Regul Pept on July 15, 2002
NPY receptors as potential targets for anti-obesity drug development. Br J Pharmacol (2011) 0.96
Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells. Br J Pharmacol (2003) 0.95
BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes. Br J Pharmacol (2005) 0.83
Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis toxin-sensitive G-proteins. Regul Pept (2007) 0.79
Importance of a N-terminal aspartate in the internalization of the neuropeptide Y Y2 receptor. Eur J Pharmacol (2008) 0.79
Neuropeptide Y receptors: a promising target for cancer imaging and therapy. Regen Biomater (2015) 0.77
Non-specific binding and general cross-reactivity of Y receptor agonists are correlated and should importantly depend on their acidic sectors. Peptides (2010) 0.75
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (2001) 57.23
Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study. Neuro Oncol (2010) 2.04
Improved detection of intraventricular cysticercal cysts with the use of three-dimensional constructive interference in steady state MR sequences. AJNR Am J Neuroradiol (2000) 1.92
Ras transformation requires metabolic control by 6-phosphofructo-2-kinase. Oncogene (2006) 1.68
Leptin does not play a major role in platelet aggregation in obesity and leptin deficiency. Obes Res (2001) 1.50
Platelet function in euthyroid patients undergoing thyroidectomy in women. Eur Rev Med Pharmacol Sci (2013) 1.42
A monoclonal antibody to human platelet glycoprotein IIIa detects a related protein in cultured human endothelial cells. J Clin Invest (1985) 1.38
Effects of land-use changes on landslides in a landslide-prone area (Ardesen, Rize, NE Turkey). Environ Monit Assess (2008) 1.29
Active immunization alters the plasma nicotine concentration in rats. J Pharmacol Exp Ther (1997) 1.23
Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem (1995) 1.12
A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling. Oncogene (2011) 1.09
Distinct interaction of human and guinea pig histamine H2-receptor with guanidine-type agonists. Mol Pharmacol (2001) 1.08
GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists. Eur J Pharmacol (1998) 1.08
Some effects of preservatives on the development of bacterial spores. J Appl Bacteriol (1969) 1.08
Nicotine administration enhances NPY expression in the rat hypothalamus. Brain Res (2000) 1.05
Binding of aluminium ions by Staphylococcus aurens 893. Experientia (1968) 1.02
A reversible inhibition of the germination of bacterial spores. Can J Microbiol (1968) 1.01
Stimulation of both aerobic glycolysis and Na(+)-K(+)-ATPase activity in skeletal muscle by epinephrine or amylin. Am J Physiol (1999) 1.01
Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2. Am J Physiol (1997) 0.99
Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met17]NPY), NPY analog ([norLeu4]NPY) and peptide YY. Regul Pept (1987) 0.99
Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors. Endocrinology (1989) 0.98
Evolutionary conservation of synaptosome-associated protein 25 kDa (SNAP-25) shown by Drosophila and Torpedo cDNA clones. J Biol Chem (1993) 0.96
Central nervous system receptors involved in mediating the inhibitory action of neuropeptide Y on luteinizing hormone secretion in the male rhesus monkey (Macaca mulatta). J Neuroendocrinol (2003) 0.96
Prospective intellectual testing in children with brain tumors. Ann Neurol (1988) 0.96
Reversible and irreversible labeling and autoradiographic localization of the cerebral histamine H2 receptor using [125I]iodinated probes. Proc Natl Acad Sci U S A (1990) 0.96
Strong evolutionary conservation of neuropeptide Y: sequences of chicken, goldfish, and Torpedo marmorata DNA clones. Proc Natl Acad Sci U S A (1992) 0.95
The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1/ETO. Oncogene (2011) 0.94
Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor. Eur J Biochem (2001) 0.94
Neuropeptide Y Y2 receptor in health and disease. Br J Pharmacol (2007) 0.93
Hypercalcemia in coccidioidomycosis. Am J Med (1984) 0.93
Regulation of feeding-associated peptides and receptors by nicotine. Mol Neurobiol (2001) 0.92
Antispasmodic activity of Thymus vulgaris extract on the isolated guinea-pig trachea: discrimination between drug and ethanol effects. Planta Med (1999) 0.92
Nicotine enhances the biosynthesis and secretion of transthyretin from the choroid plexus in rats: implications for beta-amyloid formation. J Neurosci (2000) 0.92
Promotion of beta-structure by interaction of diabetes associated polypeptide (amylin) with phosphatidylcholine. Biochim Biophys Acta (1992) 0.91
Interaction of synthetic peptides of apolipoprotein C-II and lipoprotein lipase at monomolecular lipid films. Biochim Biophys Acta (1986) 0.91
Neuropeptide Y treatment and food deprivation increase cyclic AMP response element-binding in rat hypothalamus. Mol Pharmacol (1997) 0.91
Pharmacokinetics and tissue distribution of bovine testicular hyaluronidase and vinblastine in mice: an attempt to optimize the mode of adjuvant hyaluronidase administration in cancer chemotherapy. Cancer Lett (1998) 0.91
Effects of neuropeptide Y, NPY analog (norleucine4-NPY), galanin and neuropeptide K on LH release in ovariectomized (ovx) and ovx estrogen, progesterone-treated rats. Peptides (1988) 0.90
Cloning and characterization of a novel neuropeptide Y receptor subtype in the zebrafish. DNA Cell Biol (1997) 0.90
Molecular cloning of a functional human thyrotropin-releasing hormone receptor. Biochem Biophys Res Commun (1993) 0.89
Region-specific transcriptional response to chronic nicotine in rat brain. Brain Res (2001) 0.89
Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor. Mol Pharmacol (1996) 0.89
Substitution of Ser61----Gly61 in human apolipoprotein C-II does not alter its activation of lipoprotein lipase. Chem Phys Lipids (1986) 0.89
The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning. Mol Pharmacol (2001) 0.88
Effect of methylenetetrahydrofolate reductase 677 C-T, 1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients. Thromb Res (2000) 0.88
Novel analogues of neuropeptide Y with a preference for the Y1-receptor. Eur J Biochem (2001) 0.87
Anorexia following the intrahypothalamic administration of amylin. Brain Res (1991) 0.87
Coordinate and divergent regulation of corticotropin-releasing factor (CRF) and CRF-binding protein expression in an immortalized amygdalar neuronal cell line. Endocrinology (1999) 0.87
Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease. Free Radic Res (2013) 0.86
Hypothalamic administration of cAMP agonist/PKA activator inhibits both schedule feeding and NPY-induced feeding in rats. Peptides (2003) 0.86
Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity. Biochemistry (1995) 0.86
Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.85
Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo. Peptides (1997) 0.85
Quantitation of hyaluronidases by the Morgan-Elson reaction: comparison of the enzyme activities in the plasma of tumor patients and healthy volunteers. Cancer Lett (1998) 0.85
Origins of the many NPY-family receptors in mammals. Peptides (2001) 0.85
Evolution of the neuropeptide Y family and its receptors. Ann N Y Acad Sci (1998) 0.84
Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes. Am J Physiol (1991) 0.84
Anorexia following the systemic injection of amylin. Brain Res (1993) 0.83
Proximal jejunal and biliary effects on the enteroinsular axis. Surgery (1990) 0.83
Heparin releases newly synthesized cell surface-associated apolipoprotein E from HepG2 cells. J Lipid Res (1993) 0.83
Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation. Mol Pharmacol (1992) 0.83
Programmable biodegradable implants. J Control Release (2001) 0.83
Antagonism of NPY-induced feeding by pretreatment with cyclic AMP response element binding protein antisense oligonucleotide. Neuropeptides (2001) 0.83
Oligomerization of the heptahelical G protein coupling receptors: a case for association using transmembrane helices. Mini Rev Med Chem (2009) 0.82
Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells. Peptides (2001) 0.82
[125I]Leu31, Pro34-PYY is a high affinity radioligand for rat PP1/Y4 and Y1 receptors: evidence for heterogeneity in pancreatic polypeptide receptors. Peptides (1997) 0.82
Evidence for Y1 and Y2 subtypes of neuropeptide Y receptors linked to opposing postjunctional effects observed in rat cardiac myocytes. Eur J Pharmacol (1997) 0.82
Independent release of peptide YY (PYY) into the circulation and ileal lumen of the awake dog. J Surg Res (1989) 0.82
NPY upregulates genes containing cyclic AMP response element in human neuroblastoma cell lines bearing Y1 and Y2 receptors: involvement of CREB. Regul Pept (1998) 0.81
Complex gene organization of synaptic protein SNAP-25 in Drosophila melanogaster. Gene (1997) 0.81
Internalization of cloned pancreatic polypeptide receptors is accelerated by all types of Y4 agonists. Regul Pept (2005) 0.81
Maintaining gut integrity during parenteral nutrition of tumor-bearing rats: effects of glucagon-like peptide 2. Nutr Cancer (2000) 0.81
Parallel inactivation of Y2 receptor and G-proteins in CHO cells by pertussis toxin. Regul Pept (2006) 0.81
Functional expression of three P2X(2) receptor splice variants from guinea pig cochlea. J Neurophysiol (2000) 0.81
Hyaluronidase pretreatment produces selective melphalan enrichment in malignant melanoma implanted in nude mice. Cancer Chemother Pharmacol (1996) 0.81
Ectopic ACTH syndrome associated with breast carcinoma. South Med J (1984) 0.81
Beneficial effect of H2-agonism and H1-antagonism in rat endotoxic shock. Shock (1994) 0.80
Self-regulation of agonist activity at the Y receptors. Peptides (2006) 0.80
Cloning and functional expression of the hNPY Y5 receptor in human endometrial cancer (HEC-1B) cells. Can J Physiol Pharmacol (2000) 0.80
Contractile effects of cardiac neuropeptides in isolated canine atrial and ventricular muscles. Am J Physiol (1989) 0.80
Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue. Mol Pharmacol (1992) 0.80
The neuropeptide Y Y1 receptor selective radioligand, [125I][Leu31,Pro34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptors. Eur J Pharmacol (1996) 0.80
Neuropeptide Y receptor subtype with unique properties cloned in the zebrafish: the zYa receptor. Brain Res Mol Brain Res (1999) 0.80
Therapeutic value of H2-receptor stimulation in congestive heart failure. Hemodynamic effects of BU-E-76, BU-E-75 and arpromidine (BU-E-50) in comparison to impromidine. Agents Actions Suppl (1991) 0.79
[D-Trp(34)] neuropeptide Y is a potent and selective neuropeptide Y Y(5) receptor agonist with dramatic effects on food intake. Peptides (2000) 0.79
Heparin prevents the binding of phospholipase A2 to phospholipid micelles: importance of the amino-terminus. Biochemistry (1991) 0.79
Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis toxin-sensitive G-proteins. Regul Pept (2007) 0.79
Similar apparent constitutive activity of human histamine H(2)-receptor fused to long and short splice variants of G(salpha). J Pharmacol Exp Ther (2001) 0.79
Molecular determinants for the high constitutive activity of the human histamine H4 receptor: functional studies on orthologues and mutants. Br J Pharmacol (2014) 0.79
Characterization of Y1, Y2 and Y5 subtypes of the neuropeptide Y (NPY) receptor in rabbit kidney. Sensitivity of ligand binding to guanine nucleotides and phospholipase C inhibitors. Regul Pept (1998) 0.79
Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuropeptide Y. Peptides (1996) 0.79
Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorectic tumor-bearing rats. Life Sci (1994) 0.79
Inhibitory and stimulatory effects of neuropeptide Y(17-36) on rat cardiac adenylate cyclase activity. Structure-function studies. J Biol Chem (1992) 0.79